CAS No.:541-25-3
Name: Chlorovinylarsine dichloride
Details Introduction
TOXICITY DATA with REFERENCE:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LCLo | inhalation | 50gm/m3/30M (50000mg/m3) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" KIDNEY, URETER, AND BLADDER: OTHER CHANGES |
Reviews of Environmental Contamination and Toxicology. Vol. 110, Pg. 75, 1989. |
dog | LD50 | intravenous | 2mg/kg (2mg/kg) | National Technical Information Service. Vol. PB158-508, | |
dog | LD50 | skin | 15mg/kg (15mg/kg) | Journal of Pathology and Bacteriology. Vol. 58, Pg. 411, 1946. | |
dog | LD50 | subcutaneous | 2mg/kg (2mg/kg) | Journal of Pathology and Bacteriology. Vol. 58, Pg. 411, 1946. | |
domestic animals - goat/sheep | LD50 | skin | 10mg/kg (10mg/kg) | National Technical Information Service. Vol. PB158-508, | |
guinea pig | LD50 | skin | 12mg/kg (12mg/kg) | Journal of Pathology and Bacteriology. Vol. 58, Pg. 411, 1946. | |
guinea pig | LD50 | subcutaneous | 1mg/kg (1mg/kg) | Journal of Pathology and Bacteriology. Vol. 58, Pg. 411, 1946. | |
guinea pig | LDLo | intraperitoneal | 2mg/kg (2mg/kg) | National Technical Information Service. Vol. PB158-508, | |
human | LCLo | inhalation | 6ppm/30M (6ppm) | National Technical Information Service. Vol. PB214-270, | |
human | LDLo | skin | 37600ug/kg (37.6mg/kg) | EHP, Environmental Health Perspectives. Vol. 98, Pg. 259, 1992. | |
mouse | LD50 | skin | 12mg/kg (12mg/kg) | National Technical Information Service. Vol. PB158-508, | |
rabbit | LD50 | intravenous | 500ug/kg (0.5mg/kg) | Journal of Pathology and Bacteriology. Vol. 58, Pg. 411, 1946. | |
rabbit | LD50 | skin | 4mg/kg (4mg/kg) | Biochemical Journal. Vol. 41, Pg. 325, 1947. | |
rabbit | LD50 | subcutaneous | 2mg/kg (2mg/kg) | Journal of Pathology and Bacteriology. Vol. 58, Pg. 411, 1946. | |
rat | LD50 | oral | 50mg/kg (50mg/kg) | EHP, Environmental Health Perspectives. Vol. 98, Pg. 259, 1992. | |
rat | LD50 | skin | 15mg/kg (15mg/kg) | National Technical Information Service. Vol. PB158-508, | |
rat | LD50 | subcutaneous | 1mg/kg (1mg/kg) | Journal of Pathology and Bacteriology. Vol. 58, Pg. 411, 1946. |
Consensus Reports:
Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program. EPA Extremely Hazardous Substances List. Arsenic and its compounds are on the Community Right-To-Know List.
SAFETY PROFILE:
A human poison by inhalation. Poison experimentally by inhalation, skin contact, subcutaneous, intraperitoneal, and intravenous routes. An experimental teratogen. A blistering-type military poison. Lewisite is absorbed through skin; as little as 2 mL on the skin can cause death. Has a delayed action similar to distilled mustard gas. This gas exhibits a systemic poisoning effect on humans. When Chlorovinylarsine dichloride (CAS NO.541-25-3) is heated to decomposition, it emits toxic fumes of Cl− and As. See also ARSENIC COMPOUNDS.
RIDADR 2927
HazardClass 6.1(a)
PackingGroup I
Standards and Recommendations:
Analytical Methods:
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione